| 000 | 01815cam a22004931i 4500 | ||
|---|---|---|---|
| 001 | on1202948251 | ||
| 003 | OCoLC | ||
| 005 | 20250508013038.0 | ||
| 006 | m d | ||
| 007 | cr ||||||||||| | ||
| 008 | 200930s2018 xx fo 000 0 eng | ||
| 040 |
_aUKMGB _beng _erda _cUKMGB _dOCLCO _dN$T |
||
| 015 |
_aGBC0F8305 _2bnb |
||
| 019 | _a1226072638 | ||
| 020 |
_a9781496389145 _q(EPUB) |
||
| 020 |
_a149638914X _q(EPUB) |
||
| 020 | _z9781496389138 | ||
| 035 |
_a2272481 _b(N$T) |
||
| 035 |
_a(OCoLC)1202948251 _z(OCoLC)1226072638 |
||
| 037 |
_a9781496389145 _bIngram Content Group |
||
| 050 | 4 | _aRC271.C5 | |
| 072 | 7 |
_aMED _x062000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.994061 _223 |
| 049 | _aMAIN | ||
| 245 | 0 | 0 |
_aHandbook of targeted cancer therapy and immunotherapy / _c[edited by] Daniel D. Karp, Gerald S. Falchook. |
| 246 | 3 | _aTargeted cancer therapy and immunotherapy | |
| 250 | _aSecond edition. | ||
| 264 | 1 |
_a[Place of publication not identified] : _bWolters Kluwer Health, _c2018. |
|
| 300 | _a1 online resource (408 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 505 | 0 | _aI: Targets by organ site -- II: Carcinogenesis from the perspective of targeted therapy and immunotherapy -- III: Molecular targets and pathways -- IV: Targeted and immunotherapy agents. | |
| 650 | 0 |
_aTumors _xChemotherapy. |
|
| 650 | 0 |
_aDrugs _xTesting. |
|
| 650 | 0 | _aClinical trials. | |
| 650 | 0 |
_aCancer _xTreatment. |
|
| 700 | 1 |
_aKarp, Daniel D., _eeditor. |
|
| 700 | 1 |
_aFalchook, Gerald S., _eeditor. |
|
| 856 | 4 | 0 |
_3EBSCOhost (requires login) _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2272481 |
| 938 |
_aEBSCOhost _bEBSC _n2272481 |
||
| 942 | _cCF | ||
| 994 |
_a92 _bN$T |
||
| 999 |
_c1913 _d1913 |
||